Mario Fernandez, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Tecnofarma
    Date added:
    Date updated:
    10/23/2024
    Relationship end date:
    04/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Grünenthal
    Date added:
    Date updated:
    10/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Merck
    Date added:
    Date updated:
    10/23/2024
    Relationship end date:
    11/11/2021
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Ferring
    Date added:
    Date updated:
    10/23/2024
    Relationship end date:
    09/09/2021
Return to Avances globales en el cáncer de vejiga (2023) - Español